An improved method with high specificity for KIR2DL1 functional allele typing

Lab Medicine

Volumn 46, Issue 3, 2015, Pages 207-213

  Bari, Rafijul ^a   Schell, Sarah ^a   Tuggle, Macal ^a   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Killer cell immunoglobulin like receptor (KIR); KIR polymorphism; KIR2DL1 allelotyping; KIRs genotyping; Natural killer (NK) cell; Single nucleotide polymorphism (SNP) assay

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KIR2DL1 PROTEIN, HUMAN;

ALLELE; AMPLICON; ARTICLE; CONTROLLED STUDY; CROSS REACTION; GENOTYPE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; DNA SEQUENCE; GENETICS; METABOLISM; PROCEDURES;

ALLELES; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KIR; RECEPTORS, KIR2DL1; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 84949682175     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMMN1K6SBRJCGD9J     Document Type: Article

References (15)

1. Bari R, Bell T, Leung W-H, et al. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245. Blood. 2009;114(25):5182-5190.
2. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol. 2008;180(6):3969-3979.
3. Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol. 2005;175(8):5222-5229.
4. VandenBussche CJ, Dakshanamurthy S, Posch PE, Hurley CK. A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J Immunol. 2006;177(8):5347-5357.
5. Falco M, Moretta L, Moretta A, Bottino C. KIR and KIR ligand polymorphism: A new area for clinical applications? Tissue Antigens. 2013;82(6):363-373.
6. Frazier WR, Steiner N, Hou L, Dakshanamurthy S, Hurley CK. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J Immunology. 2013;190(12):6198-6208.
7. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7(6):753-763.
8. Vilches C, Pando MJ, Rajalingam R, Gardiner CM, Parham P. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes. Tissue Antigens. 2000;56(5):453-456.
9. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens. 2001;57(1):22-31.
10. Gómez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens. 2002;59(3):184-193.
11. Vilches C, Castaño J, Gómez-Lozano N, Estefanía E. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens. 2007;70(5):415-422.
12. Bari R, Leung M, Turner VE, et al. Molecular determinant-based typing of KIR alleles and KIR ligands. Clin Immunol. 2011;138(3):274-281.
13. Robinson J, Halliwell JA, Marsh SGE. IMGT/HLA and the immuno polymorphism database. Meth Mol Biol. 2014;1184:109-121.
14. Shilling HG, Guethlein LA, Cheng NW, et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol. 2002;168(5):2307-2315.
15. Allele Frequencies in Worldwide Populations. http://www.allelefrequencies.net/kir6002a.asp?kir-locus=&kir-allele1=2DL1&kir-allele2=2DL1&kir-selection=&kir-population=&kir-country=United+States&kir-dataset=&kir-region=&kir-ethnic=&kir-study=&kir-order=order-1&kir-sample-size-pattern=equal&kir-sample-size=&kir-sample-year-pattern=equal&kir-sample-year=&kir-digits-pattern=equal&kir-digits=&kir-show= Accessed on: February 19, 2015